Comparative Benchmarking
In the context of the broader market, INDP competes directly with industry leaders such as GELS and MGRX. With a market capitalization of $7.74M, it holds a leading position in the sector. When comparing efficiency, INDP's gross margin of N/A stands against GELS's -707.96% and MGRX's -1139.43%. Such benchmarking helps identify whether Indaptus Therapeutics Inc is trading at a premium or discount relative to its financial performance.
